Related Experiment Video
Updated: Dec 16, 2025

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
A new look at brittle diabetes
Irl B Hirsch1, Linda M Gaudiani2
1University of Washington School of Medicine, Seattle, WA, United States of America.
Brittle diabetes, characterized by erratic blood sugar, is redefined into four distinct patient groups. Identifying and treating associated conditions can significantly improve glycemic control and outcomes.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Geriatric Medicine
Background:
- The term "brittle diabetes" historically described patients with severe glycemic variability.
- Early definitions focused on limited case studies, often involving young women with psychosocial issues.
- Erratic blood glucose levels significantly impact patient quality of life and health outcomes.
Purpose of the Study:
- To redefine "brittle diabetes" by categorizing it into four distinct life stages.
- To identify specific characteristics and associated conditions within each category.
- To highlight treatable factors contributing to glycemic instability.
Main Methods:
- Literature review and clinical case analysis.
- Categorization of patients based on life stage and contributing factors.
- Analysis of associated conditions impacting glycemic control.
Main Results:
- Redefinition of brittle diabetes into four groups: psychiatric comorbidities, underlying medical conditions, geriatric type 1 diabetes, and insulin access/food insecurity.
- Each group presents unique challenges and characteristics leading to poor glycemic control.
- Identification of treatable factors within each group offers potential for improved management.
Conclusions:
- A new framework for understanding brittle diabetes based on four distinct patient profiles.
- Recognizing these profiles allows for targeted interventions to mitigate associated conditions.
- This redefinition facilitates improved management strategies for patients with severe glycemic variability.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

